Article
Safety of implantable cardioverter-defibrillators in patients with sarcoidosis: A nationwide database analysis.
2023-08-17
Abstract excerpt
Rationale : An estimated 5% of patients with sarcoidosis develop cardiac involvement with associated complications, including life-threatening arrhythmias and sudden death. Implantable cardiac defibrillators (ICDs) have been used for primary and secondary prevention of sudden death in patients with cardiac sarcoidosis (CS). Post-ICD placement complications have been shown to be higher in CS populations. However, d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a1cca2b6-1056-50d6-93f2-5c3a9ca463f2
- DOI
- 10.22541/au.169227864.46907570/v1
